Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 23.18
+1.22 (5.56%)
Apr 1, 2025, 2:45 PM CST
Changchun BCHT Biotechnology Co. Company Description
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.
The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans.
Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
Changchun BCHT Biotechnology Co.
| Country | China |
| Founded | 2004 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,241 |
| CEO | Wei Kong |
Contact Details
Address: No. 138, Zhuoyue Street Changchun, 130103 China | |
| Website | bchtpharm.com |
Stock Details
| Ticker Symbol | 688276 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005XY6 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wei Kong | GM and Director |
| Zhaofeng Meng | Chief Financial Officer |
| Chunlai Jiang | Executive Deputy GM and Director |
| Zhe Zhang | Board Secretary |
| Bing Yu | Deputy General Manager |
| Dawei Liu | Deputy General Manager |
| Xiaohui Chen | Chief Operating Specialist |
| Wei Wei | Deputy General Manager |
| Changlin Zhu | Core Technical Staff |